Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 68 | 2024 | 6773 | 3.940 |
Why?
|
Microsatellite Instability | 18 | 2024 | 684 | 1.210 |
Why?
|
Fusobacterium nucleatum | 9 | 2021 | 163 | 1.120 |
Why?
|
Gastritis, Atrophic | 4 | 2009 | 31 | 0.810 |
Why?
|
Alkylating Agents | 1 | 2021 | 139 | 0.760 |
Why?
|
Tumor Microenvironment | 15 | 2022 | 3590 | 0.730 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 10 | 2022 | 1038 | 0.730 |
Why?
|
Proto-Oncogene Proteins B-raf | 15 | 2024 | 2043 | 0.710 |
Why?
|
Helicobacter pylori | 4 | 2009 | 383 | 0.630 |
Why?
|
Colonic Neoplasms | 8 | 2023 | 2542 | 0.600 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 426 | 0.580 |
Why?
|
Mutation | 33 | 2024 | 29786 | 0.580 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2022 | 1862 | 0.520 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 990 | 0.500 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2022 | 2938 | 0.460 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2110 | 0.440 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1585 | 0.400 |
Why?
|
DNA Methylation | 13 | 2024 | 4285 | 0.390 |
Why?
|
Adenocarcinoma | 7 | 2023 | 6364 | 0.380 |
Why?
|
Metabolomics | 1 | 2019 | 1485 | 0.380 |
Why?
|
Oncogene Proteins | 1 | 2014 | 749 | 0.360 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3143 | 0.360 |
Why?
|
Fusobacterium Infections | 2 | 2021 | 53 | 0.340 |
Why?
|
Gastric Mucosa | 3 | 2009 | 599 | 0.340 |
Why?
|
Stem Cells | 5 | 2024 | 3567 | 0.340 |
Why?
|
Endometrial Neoplasms | 2 | 2016 | 1351 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5172 | 0.330 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4262 | 0.320 |
Why?
|
CpG Islands | 8 | 2024 | 1170 | 0.310 |
Why?
|
Stomach Neoplasms | 4 | 2023 | 1332 | 0.310 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 10 | 2024 | 1692 | 0.300 |
Why?
|
Humans | 100 | 2024 | 744366 | 0.280 |
Why?
|
Genomics | 8 | 2023 | 5717 | 0.260 |
Why?
|
DNA, Bacterial | 4 | 2018 | 1465 | 0.260 |
Why?
|
Pathology, Molecular | 2 | 2019 | 326 | 0.260 |
Why?
|
Germ-Line Mutation | 7 | 2022 | 1788 | 0.260 |
Why?
|
Melanoma | 2 | 2023 | 5511 | 0.250 |
Why?
|
Immunotherapy | 5 | 2021 | 4446 | 0.250 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5263 | 0.250 |
Why?
|
Gene Expression Profiling | 8 | 2020 | 9445 | 0.250 |
Why?
|
Microsatellite Repeats | 2 | 2019 | 802 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2022 | 8432 | 0.230 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9647 | 0.220 |
Why?
|
Single-Cell Analysis | 4 | 2021 | 2182 | 0.220 |
Why?
|
Neoplasms | 10 | 2024 | 21696 | 0.220 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1636 | 0.210 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 85 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1837 | 0.210 |
Why?
|
Kynurenine | 2 | 2019 | 139 | 0.210 |
Why?
|
Biological Evolution | 1 | 2008 | 1077 | 0.210 |
Why?
|
Asparaginase | 2 | 2020 | 236 | 0.210 |
Why?
|
Keloid | 1 | 2022 | 50 | 0.200 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 146 | 0.200 |
Why?
|
DNA Glycosylases | 1 | 2022 | 128 | 0.200 |
Why?
|
Epithelium | 1 | 2006 | 1679 | 0.190 |
Why?
|
Lymphocytes | 3 | 2020 | 2617 | 0.190 |
Why?
|
Phenotype | 11 | 2024 | 16367 | 0.190 |
Why?
|
Middle Aged | 36 | 2024 | 213390 | 0.190 |
Why?
|
Loss of Heterozygosity | 2 | 2020 | 684 | 0.180 |
Why?
|
Prospective Studies | 19 | 2024 | 53290 | 0.180 |
Why?
|
Genomic Islands | 1 | 2020 | 51 | 0.180 |
Why?
|
Aged | 33 | 2024 | 163288 | 0.180 |
Why?
|
Cell Line, Tumor | 9 | 2022 | 16690 | 0.180 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2020 | 86 | 0.180 |
Why?
|
Cyclooxygenase 2 | 2 | 2020 | 612 | 0.180 |
Why?
|
Carcinoma | 3 | 2016 | 2375 | 0.180 |
Why?
|
Prognosis | 16 | 2023 | 29060 | 0.170 |
Why?
|
5'-Nucleotidase | 1 | 2020 | 160 | 0.170 |
Why?
|
Colon | 4 | 2020 | 1772 | 0.170 |
Why?
|
Granulocytes | 1 | 2021 | 548 | 0.170 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.170 |
Why?
|
Paraffin Embedding | 1 | 2020 | 299 | 0.170 |
Why?
|
Age of Onset | 2 | 2023 | 3270 | 0.170 |
Why?
|
Tissue Fixation | 1 | 2020 | 241 | 0.170 |
Why?
|
Spheroids, Cellular | 1 | 2021 | 351 | 0.170 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2023 | 379 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 316 | 0.160 |
Why?
|
Formaldehyde | 1 | 2020 | 353 | 0.160 |
Why?
|
Female | 45 | 2024 | 380193 | 0.160 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 532 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2018 | 163 | 0.160 |
Why?
|
Bifidobacterium | 1 | 2018 | 100 | 0.160 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.160 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3707 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6539 | 0.150 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 602 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 4 | 2023 | 5534 | 0.150 |
Why?
|
T-Lymphocytes | 5 | 2022 | 10183 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 563 | 0.150 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2021 | 1369 | 0.150 |
Why?
|
Tryptophan | 1 | 2019 | 478 | 0.150 |
Why?
|
Coffee | 1 | 2022 | 578 | 0.150 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 665 | 0.150 |
Why?
|
Jews | 1 | 2019 | 385 | 0.150 |
Why?
|
Epithelial Cells | 2 | 2006 | 3690 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2021 | 542 | 0.140 |
Why?
|
Male | 38 | 2024 | 350115 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 287 | 0.140 |
Why?
|
Dietary Fiber | 1 | 2020 | 760 | 0.140 |
Why?
|
Immunohistochemistry | 5 | 2021 | 11366 | 0.140 |
Why?
|
Metabolome | 2 | 2020 | 895 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2019 | 4479 | 0.140 |
Why?
|
Calcium, Dietary | 1 | 2019 | 526 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2020 | 3595 | 0.140 |
Why?
|
Follow-Up Studies | 13 | 2024 | 39052 | 0.140 |
Why?
|
Mutagenesis | 1 | 2020 | 1264 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 4 | 2022 | 890 | 0.130 |
Why?
|
Inheritance Patterns | 1 | 2018 | 340 | 0.130 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2133 | 0.130 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1276 | 0.130 |
Why?
|
Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.130 |
Why?
|
Incidence | 6 | 2023 | 20952 | 0.130 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 78 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 350 | 0.130 |
Why?
|
Medical History Taking | 1 | 2019 | 784 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1230 | 0.130 |
Why?
|
Adaptive Immunity | 2 | 2021 | 714 | 0.130 |
Why?
|
Fruit | 1 | 2020 | 1142 | 0.120 |
Why?
|
Monocytes | 2 | 2021 | 2596 | 0.120 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3037 | 0.120 |
Why?
|
Vegetables | 1 | 2020 | 1182 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 292 | 0.120 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.120 |
Why?
|
Helicobacter Infections | 2 | 2009 | 387 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 721 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2023 | 11525 | 0.120 |
Why?
|
Cohort Studies | 10 | 2023 | 40559 | 0.120 |
Why?
|
Peptides | 2 | 2024 | 4410 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 254 | 0.120 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 188 | 0.120 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1941 | 0.120 |
Why?
|
Adult | 21 | 2023 | 214052 | 0.110 |
Why?
|
Medical Oncology | 2 | 2023 | 2267 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1660 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1312 | 0.110 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1903 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2022 | 3554 | 0.110 |
Why?
|
Weight Loss | 1 | 2024 | 2625 | 0.110 |
Why?
|
Genome, Bacterial | 2 | 2008 | 760 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2018 | 3480 | 0.100 |
Why?
|
Autophagy | 1 | 2020 | 1297 | 0.100 |
Why?
|
Oncogenes | 1 | 2017 | 1265 | 0.100 |
Why?
|
Escherichia coli | 2 | 2022 | 4217 | 0.100 |
Why?
|
Cell Lineage | 1 | 2020 | 2504 | 0.100 |
Why?
|
Sequence Analysis, DNA | 4 | 2017 | 4805 | 0.100 |
Why?
|
Lymphocyte Count | 3 | 2020 | 793 | 0.100 |
Why?
|
Lung Neoplasms | 4 | 2022 | 13104 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3799 | 0.090 |
Why?
|
Precancerous Conditions | 1 | 2017 | 975 | 0.090 |
Why?
|
Transcription Factors | 4 | 2022 | 12207 | 0.090 |
Why?
|
Colitis | 1 | 2018 | 1170 | 0.090 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13693 | 0.090 |
Why?
|
Mice | 11 | 2022 | 81201 | 0.090 |
Why?
|
Mice, Nude | 3 | 2022 | 3689 | 0.090 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 645 | 0.090 |
Why?
|
Pyridines | 1 | 2021 | 2825 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2046 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7721 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1988 | 0.080 |
Why?
|
Smoking | 2 | 2022 | 8987 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1939 | 0.070 |
Why?
|
Risk Factors | 10 | 2024 | 72296 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 2016 | 1205 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2505 | 0.070 |
Why?
|
Sweden | 1 | 2009 | 1341 | 0.070 |
Why?
|
Genetic Variation | 1 | 2021 | 6542 | 0.070 |
Why?
|
Expressed Sequence Tags | 1 | 2006 | 255 | 0.070 |
Why?
|
Animals | 12 | 2022 | 168768 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11031 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2708 | 0.060 |
Why?
|
Chronic Disease | 3 | 2009 | 9145 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3283 | 0.060 |
Why?
|
Organoids | 2 | 2022 | 701 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8642 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 6 | 2022 | 17446 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Bacterial Adhesion | 1 | 2006 | 316 | 0.060 |
Why?
|
Rectum | 2 | 2019 | 904 | 0.060 |
Why?
|
Diet | 2 | 2022 | 7937 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5223 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7914 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5749 | 0.060 |
Why?
|
Disease Progression | 4 | 2021 | 13286 | 0.060 |
Why?
|
Young Adult | 4 | 2023 | 56429 | 0.060 |
Why?
|
Gene Library | 1 | 2006 | 1074 | 0.060 |
Why?
|
DNA, Complementary | 1 | 2006 | 2050 | 0.050 |
Why?
|
DNA Damage | 2 | 2024 | 2432 | 0.050 |
Why?
|
Allelic Imbalance | 1 | 2022 | 77 | 0.050 |
Why?
|
Cell Separation | 1 | 2008 | 1751 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12356 | 0.050 |
Why?
|
Lasers | 1 | 2006 | 952 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 193 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2021 | 329 | 0.050 |
Why?
|
Calmodulin | 1 | 2022 | 209 | 0.050 |
Why?
|
Signal Transduction | 3 | 2022 | 23404 | 0.050 |
Why?
|
Intention | 1 | 2024 | 342 | 0.050 |
Why?
|
Body Size | 1 | 2024 | 461 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 174 | 0.050 |
Why?
|
Meat | 1 | 2024 | 592 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 402 | 0.050 |
Why?
|
Hematoxylin | 1 | 2020 | 64 | 0.050 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 72 | 0.050 |
Why?
|
Pyrimidinones | 1 | 2023 | 370 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2023 | 6896 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9240 | 0.050 |
Why?
|
Albumins | 1 | 2023 | 568 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 647 | 0.040 |
Why?
|
Bystander Effect | 1 | 2020 | 81 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12788 | 0.040 |
Why?
|
Models, Genetic | 2 | 2021 | 3493 | 0.040 |
Why?
|
Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2019 | 10 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2023 | 826 | 0.040 |
Why?
|
Intestine, Small | 1 | 2006 | 1240 | 0.040 |
Why?
|
Consensus Sequence | 1 | 2020 | 378 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2023 | 13035 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2017 | 1783 | 0.040 |
Why?
|
Logistic Models | 3 | 2021 | 13409 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3751 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2020 | 435 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 63107 | 0.040 |
Why?
|
Asparagine | 1 | 2019 | 122 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2949 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 279 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 409 | 0.040 |
Why?
|
Edema | 1 | 2023 | 789 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 97 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20130 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2021 | 21748 | 0.040 |
Why?
|
Genes, ras | 1 | 2021 | 690 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1106 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 967 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 711 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 954 | 0.040 |
Why?
|
Endoscopy | 1 | 2008 | 1787 | 0.040 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2020 | 338 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1758 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 18111 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 560 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 468 | 0.040 |
Why?
|
Genome | 1 | 2006 | 1807 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 315 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 970 | 0.040 |
Why?
|
United States | 6 | 2021 | 69872 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 634 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7658 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2725 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1879 | 0.040 |
Why?
|
Epigenomics | 1 | 2022 | 903 | 0.040 |
Why?
|
Tumor Burden | 1 | 2022 | 1915 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2021 | 810 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2018 | 169 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 838 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1707 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1341 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 376 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1355 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2009 | 3854 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1101 | 0.030 |
Why?
|
Gene Expression | 2 | 2022 | 7798 | 0.030 |
Why?
|
Paclitaxel | 1 | 2023 | 1708 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2024 | 11486 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1142 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2804 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1783 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1014 | 0.030 |
Why?
|
Isoenzymes | 1 | 2020 | 1728 | 0.030 |
Why?
|
Cell Line | 1 | 2009 | 16000 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1366 | 0.030 |
Why?
|
Genetic Markers | 1 | 2021 | 2634 | 0.030 |
Why?
|
beta Catenin | 1 | 2020 | 1059 | 0.030 |
Why?
|
DNA Helicases | 1 | 2020 | 861 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2019 | 594 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1656 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 720 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2019 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1525 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2022 | 10483 | 0.030 |
Why?
|
Age Factors | 2 | 2021 | 18373 | 0.030 |
Why?
|
Fluorouracil | 1 | 2018 | 1619 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 980 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2700 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1376 | 0.030 |
Why?
|
Computational Biology | 1 | 2006 | 3519 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4185 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3390 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3914 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1707 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4671 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2022 | 2441 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 15520 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2018 | 735 | 0.030 |
Why?
|
HLA Antigens | 1 | 2018 | 1382 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3616 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7730 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4208 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 817 | 0.030 |
Why?
|
Cell Survival | 1 | 2022 | 5882 | 0.020 |
Why?
|
Software | 1 | 2006 | 4441 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2917 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4554 | 0.020 |
Why?
|
Adenoma | 1 | 2021 | 2174 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 12262 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3219 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2890 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.020 |
Why?
|
Nurses | 1 | 2019 | 2462 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4222 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1023 | 0.020 |
Why?
|
Obesity | 2 | 2023 | 12746 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9584 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4328 | 0.020 |
Why?
|
Life Style | 1 | 2020 | 3835 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3702 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2804 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3721 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6933 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77460 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3486 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1580 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 4642 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 2408 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4420 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10400 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.020 |
Why?
|
Proteins | 1 | 2022 | 6100 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5660 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.020 |
Why?
|
Neurons | 1 | 2006 | 9340 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1480 | 0.020 |
Why?
|
Base Pairing | 1 | 2006 | 141 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10252 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 12721 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5856 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15078 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4851 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19233 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3514 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3646 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
Critical Care | 1 | 2016 | 2647 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4253 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8319 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6311 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9724 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
Genomic Instability | 1 | 2006 | 695 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10637 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12244 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2006 | 2556 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 13882 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25628 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 85779 | 0.010 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2006 | 1122 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 5984 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6234 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29144 | 0.010 |
Why?
|
Infant | 1 | 2020 | 35134 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23336 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41005 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3921 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10259 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25039 | 0.010 |
Why?
|
Child | 1 | 2020 | 77709 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 12952 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20824 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18034 | 0.000 |
Why?
|